Corbus Pharmaceuticals Holdings (CRBP) Cash from Restructuring (2022 - 2025)
Corbus Pharmaceuticals Holdings' (CRBP) quarterly Cash from Restructuring came in at -$267000.0 in Q3 2025, down 13.62% year-on-year from -$309088.7 in Q3 2024, and down 3.49% quarter-over-quarter from -$258000.0 in Q2 2025.
Corbus Pharmaceuticals Holdings (CRBP) Cash from Restructuring (2022 - 2025) Analysis & Trends
Corbus Pharmaceuticals Holdings' Cash from Restructuring history runs 4 years deep, the most recent figure standing at -$267000.0 for Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Corbus Pharmaceuticals Holdings | 164.14 Mn | 136.33 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -267,000.00 |
| Jun 30, 2025 | -258,000.00 |
| Mar 31, 2025 | -251,000.00 |
| Sep 30, 2024 | -235,000.00 |
| Jun 30, 2024 | -229,000.00 |
| Mar 31, 2024 | -222,000.00 |
| Sep 30, 2023 | -208,000.00 |
| Jun 30, 2023 | -202,216.00 |
| Mar 31, 2023 | -195,784.00 |
| Sep 30, 2022 | -184,004.00 |
| Jun 30, 2022 | -178,299.00 |
| Mar 31, 2022 | -172,734.00 |